Abstract
In the search for the prevalence and distribution pattern of Gs-α gene mutations in differentiated thyroid tumors we examined 66 tumor tissue samples for the presence of mutations at “hot-spot” codons 201 and 227 using methods based on the polymerase chain reaction, subcloning and sequencing. the prevailing type of singlebase substitution at codon 201 (71.4%) corresponded to the replacement of the wild-type sequence CGT (Arg) with TGT (Cys). The fragments of the Gs-α gene, including codon 201 or 227 from five follicular carcinomas and one follicular adenoma, were subcloned inEscherichia coli and it was found that the proportion of alleles with mutated codon 201 varied from 3.2% to 43%. Sequencing of the corresponding region has confirmed preliminary data indicating that the single-base changes CGT (Arg) to TGT (Cys) or CGT to CAT (His) occurred. There was only a weak correlation between the prevalence of cells bearing a mutation in the Gs-α gene and the level of Gs-α protein expression in the corresponding thyroid tumors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- RFLP :
-
restriction-fragment-length polymorphism
- MSOH :
-
mutation-specific oligonucleotide hybridization
- PCR :
-
polymerase chain reaction
References
Bos JL (1989)ras oncogenes in human cancer: a review. Cancer Res 49:4682–4689
Gorelov VN, Röher H-D, Goretzki PE (1994) A method to increase the sensitivity of mutation specific oligonucleotide hybridization using asymmetric polymerase chain reaction (PCR). Biochem Biophys Res Commun 200:365–369
Gorelov VN, Dumon K, Barteneva NS, Palm D, Röher H-D, Goretzki PE (1995) Overexpression of Gs-α subunit in thyroid tumors bearing a mutated Gs-α gene. J Cancer Res Clin Oncol 121:219–224
Goretzki PE, Lyons J, Stacy-Phipps S, Rosenau W, Demeure M, Clark OH, McCormic Röher H-D, Bourne HR (1992) Mutational activity of RAS and GSP oncogenes in differentiated thyroid cancer and their applications. World J Surg 16:576–581
Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L (1989) GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 340:692–696
Landis CA, Harsh G, Lyons J, Davis RL, McCormic F, Bourne HR (1990) Clinical characteristics of acromegalic patients whose pituatry tumors contain mutant Gs protein. J Endocrinol Metab 71:1416–1420
Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ (1991) Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51:3497–3502
Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H, Duh Q-Y, Clark OH, Kawasaki E, Bourne HR, McCormic F (1990) Two G protein oncogenes in human endocrine tumors. Science 249:665–659
Matsuo K, Friedman E, Gejman PV, Fagin JA (1993) The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the α-subunit of Gs in human thyroid neoplasms. J Clin Endocrinol Metab 76:1448–1451
Miller RT, Masters SB, Sullivan KA, Biederman B, Bourne HR (1988) A mutation that prevents GTP-dependent activation of the α chain of Gs. Nature 334:712–715
Müller A, Gorelov V, Möllner S, Röher H-D, Goretzki PE (1994) Importance of adenylate cyclase and G-protein mutations in prognosis of differentiated thyroid tumors (in German) In: Trede M, Siewert JR, Hartel W (eds) Chirurgishes Forum 1994 für experimentelle und klinische Forchung. Springer, Berlin Heidelberg New York, pp 349–353
Sanger F, Nickeln S, Coulson AR (1977) DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Schwindinger WF, Francomano CA, Levin MA (1992) Identification of a mutation in the gene encoding the α subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albricht syndrome. Proc Natl Acad Sci USA 89:5152–5156
Siperstein AE, Miller RA, Landis C, Bourne H, Clark OH (1991) Increased stimulatory G protein in neoplastic human thyroid tissues. Surgery 110:949–955
Spada A, Arosio M, Bochiccio D, Bazzoni N, Vallar L, Bassetti M, Faglia G (1990) Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71: 1421–1426
Suarez HG, du Villard JA, Caillou B, Schlumberger M, Permentier C, Monier R (1991) GSP mutations in human thyroid tumors. Oncogene 6:677–679
Author information
Authors and Affiliations
Additional information
This work was supported by a grant from Deutsche Forschungs-gemeinschaft (Go 356/3-1)
Rights and permissions
About this article
Cite this article
Gorelov, V.N., Gyenes, M., Neser, F. et al. Distribution of Gs-α activating mutations in human thyroid tumors measured by subcloning. J Cancer Res Clin Oncol 122, 453–457 (1996). https://doi.org/10.1007/BF01187156
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01187156